Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionPrivate Wealth Partners, LLC
Latest Disclosed Ownership6,000 shares
Latest Disclosed Value $ 836,220
Private Wealth Partners, LLC ownership in GILD / Gilead Sciences, Inc.

On April 28, 2026 - Private Wealth Partners, LLC filed a 13F-HR form disclosing ownership of 6,000 shares of Gilead Sciences, Inc. (CH:GILD) valued at $836,220 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 27, 2026 disclosing 6,000 shares of Gilead Sciences, Inc.. This represents a change in shares of 0.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-28 2026-03-31 13F GILEAD SCIENCES COM 375558103 6,000 0 0.00 836 13.59 0.0644
2026-01-27 2025-12-31 13F GILEAD SCIENCES COM 375558103 6,000 0 0.00 736 10.51 0.0522
2025-11-04 2025-09-30 13F GILEAD SCIENCES COM 375558103 6,000 0 0.00 666 0.15 0.0475
2025-08-01 2025-06-30 13F GILEAD SCIENCES COM 375558103 6,000 0 0.00 665 -1.04 0.0519
2025-04-22 2025-03-31 13F GILEAD SCIENCES COM 375558103 6,000 -3,050 -33.70 672 -19.52 0.0557
2025-02-03 2024-12-31 13F GILEAD SCIENCES COM 375558103 9,050 50 0.56 836 10.74 0.0640
2024-10-29 2024-09-30 13F GILEAD SCIENCES COM 375558103 9,000 -15,094 -62.65 755 -54.39 0.0601
2024-08-08 2024-06-30 13F GILEAD SCIENCES COM 375558103 24,094 -47,147 -66.18 1,653 -68.32 0.1226
2024-05-09 2024-03-31 13F GILEAD SCIENCES COM 375558103 71,241 26,350 58.70 5,218 43.51 0.4173
2024-02-02 2023-12-31 13F GILEAD SCIENCES COM 375558103 44,891 5,827 14.92 3,637 24.22 0.3074
2023-11-07 2023-09-30 13F GILEAD SCIENCES COM 375558103 39,064 1,815 4.87 2,927 1.99 0.2799
2023-08-03 2023-06-30 13F GILEAD SCIENCES COM 375558103 37,249 16,785 82.02 2,871 69.12 0.2639
2023-05-04 2023-03-31 13F GILEAD SCIENCES COM 375558103 20,464 540 2.71 1,698 -0.76 0.1695
2023-01-25 2022-12-31 13F GILEAD SCIENCES COM 375558103 19,924 84 0.42 1,710 39.71 0.1957
2022-10-27 2022-09-30 13F GILEAD SCIENCES COM 375558103 19,840 -1,000 -4.80 1,224 -4.97 0.1564
2022-08-02 2022-06-30 13F GILEAD SCIENCES COM 375558103 20,840 -56,570 -73.08 1,288 -72.01 0.1497
2022-05-02 2022-03-31 13F GILEAD SCIENCES COM 375558103 77,410 -195 -0.25 4,602 -18.33 0.4122
2022-02-07 2021-12-31 13F GILEAD SCIENCES COM 375558103 77,605 44,195 132.28 5,635 141.43 0.4762
2021-11-12 2021-09-30 13F GILEAD SCIENCES COM 375558103 33,410 3,555 11.91 2,334 13.52 0.2168
2021-08-12 2021-06-30 13F GILEAD SCIENCES COM 375558103 29,855 6,595 28.35 2,056 36.79 0.1902
2021-05-04 2021-03-31 13F GILEAD SCIENCES COM 375558103 23,260 7,300 45.74 1,503 61.61 0.1592
2021-02-03 2020-12-31 13F GILEAD SCIENCES COM 375558103 15,960 -136,575 -89.54 930 -90.35 0.1009
2020-10-29 2020-09-30 13F GILEAD SCIENCES COM 375558103 152,535 9,100 6.34 9,639 -12.66 1.1273
2020-07-31 2020-06-30 13F GILEAD SCIENCES COM 375558103 143,435 128,835 882.43 11,036 911.55 1.5122
2020-04-24 2020-03-31 13F GILEAD SCIENCES COM 375558103 14,600 14,600 1,091 0.1840
2016-10-18 2016-09-30 13F GILEAD SCIENCES COM 375558103 0 -53,935 -100.00 0 -100.00
2016-07-27 2016-06-30 13F GILEAD SCIENCES COM 375558103 53,935 -7,440 -12.12 4,499 -20.20 1.0812
2016-04-25 2016-03-31 13F GILEAD SCIENCES COM 375558103 61,375 12,350 25.19 5,638 13.65 1.3550
2016-01-25 2015-12-31 13F GILEAD SCIENCES COM 375558103 49,025 29,760 154.48 4,961 162.21 1.1596
2015-10-26 2015-09-30 13F GILEAD SCIENCES COM 375558103 19,265 5,675 41.76 1,892 18.92 0.4761
2015-07-23 2015-06-30 13F GILEAD SCIENCES COM 375558103 13,590 2,150 18.79 1,591 41.67 0.3594
2015-04-27 2015-03-31 13F/A-1 GILEAD SCIENCES COM 375558103 11,440 3,110 37.33 1,123 43.06 0.2585
2015-04-22 2015-03-31 13F GILEAD SCIENCES COM 375558103 8,330 785
2015-01-23 2014-12-31 13F GILEAD SCIENCES COM 375558103 8,330 -34,510 -80.56 785 -82.79 0.1845
2014-10-27 2014-09-30 13F GILEAD SCIENCES COM 375558103 42,840 4,635 12.13 4,560 43.94 1.0012
2014-08-05 2014-06-30 13F GILEAD SCIENCES COM 375558103 38,205 38,205 3,168 0.6961
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.